Watch: New Cancer Drugs from Artificial Life

In 2014 artificial life was made for the first time.

Two new nucleotides were added—X and Y—to the standard four: A, G, T, C

These new nucleotides allow for the addition of unnatural amino acids to create entirely new kinds of proteins.

Now biotech company Synthorx has announced that they have developed a new cancer drug using these artificial bacteria.

Interleukin-2 has been studied for decades as an immune system-stimulating cancer therapy, but it unfortunately comes with some serious side effects and is often unpredictable.

By adding an extra unnatural amino acid to Interleukin, Synthorx created a “Synthorin” that prolongs the protein’s activity while eliminating its immune-suppressing effects.

So, it turns out that creating artificial life is more than a cool laboratory trick—it may turn out to be a great new way to create new drugs as well.

http://www.sandiegouniontribune.com/business/biotech/sd-me-synthorx-cancer-20180430-story.html

Follow us on social media for the latest updates in B2B!

Image

Latest

SEO
SEO in the Age of AI: What CMOs and CEOs Need to Know About AEO and GEO
November 20, 2025

In an era when AI-driven search experiences are reshaping how customers discover brands, marketing leaders are navigating a confusing landscape of new acronyms, shifting behaviors, and bold industry predictions. Despite widespread claims that “SEO is dead,” the data tells a different story: organic search traffic has continued to grow even as platforms like ChatGPT, Gemini,…

Read More
From the Bench: How Research Can Help Us Build a Future-Ready Global Healthcare Workforce | Lauren Herckis | EP 18
From the Bench: How Research Can Help Us Build a Future-Ready Global Healthcare Workforce
November 20, 2025

The Care Anywhere podcast is taking listeners behind the scenes of global health workforce research with a brand-new series: From the Bench. In this kickoff episode, host Lea Sims talks with Dr. Lauren Herckis of TruMerit about how research can move from data to real-world impact — revealing how evidence, collaboration, and curiosity are driving…

Read More
purpose
Elevate Your Career Journey by Choosing Purpose, Practicing Intentionality, and Building a Culture of Belonging
November 19, 2025

Purpose doesn’t just shape what we do—it shapes how we grow. When we choose to move through our careers with intention, we start noticing the moments that build trust, the conversations that deepen understanding, and the relationships that elevate our impact. This episode of Professional Quotient digs into what it really means to show up…

Read More
Christie Linebarger
Christie Linebarger’s Journey to Leadership: Grit, Growth & Leading with Heart
November 19, 2025

Leadership conversations are shifting as companies navigate rapid change, tighter labor markets, and evolving employee expectations. Teams want leaders who show up with humility, clarity, and a genuine investment in people—traits that can’t be faked and can’t be automated. And with studies consistently linking team engagement to the quality of direct leadership, understanding how effective…

Read More